Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes
CA 2448947 C · Owner: Biovectys · Inventors: Serguera, Che; He, Yi; Mallet, Jacques
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a defective lentivirus which is pseudotyped with a lyssavirus envelope of the PV (rabies virus) or MOK type (Mokola virus) for example, and to the use thereof, especially in the preparation of a composition for in vivo transfer of genes in astrocytes and also for the treatment of disorders of the central nervous system.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 31, 2002 and granted July 12, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 31, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.